David Z Allen1, Neil Gross2, Marc-Elie Nader2

  • 1Department of Otorhinolaryngology, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

Head & neck
|October 25, 2025
PubMed
概括

新辅助免疫疗法显著改善了晚期外耳皮肤状细胞癌 (pCSCC) 的存活率. 这种方法提高了与前期手术相比的无事件生存率和整体生存率.